ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Versatile DNA-Encoded Library Platform for the Discovery of Highly Cooperative Chemical Inducers of Proximity.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Chemical-induced proximity, particularly via molecular glues, represents a rapidly advancing therapeutic paradigm. Expanding the scope of proximity-based therapeutics requires generalizable discovery platforms that can be easily tailored to diverse presenter proteins. Here, we report a versatile DNA-encoded library (DEL) strategy designed to identify highly cooperative chemical inducers of proximity (CIPs) for multiple presenter proteins. By leveraging a novel precursor library constructed via on-DNA strained allene cycloadditions, we generated three distinct CIP-DELs biased toward Cereblon (CRBN), VHL, and FKBP12. Screening the CRBN-focused library with BRD9 identified B67b, a novel compound that mediates ternary complex formation between CRBN and BRD9 with nanomolar potency and strong molecular glue-like cooperativity (α >300). B67b engages BRD9 in a CRBN-dependent manner, a characteristic of classical molecular glues, and its high cooperativity is driven by the synergistic contribution of all its structural and stereochemical components. This work establishes a scalable, generalizable framework for repurposing generic DELs into presenter-specific screening tools, offering a powerful approach to accelerate the discovery of CIP therapeutics for a broad range of targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.